The Pulse

Feature15 Jun 2026

Wearables, Nearables, And The New Body-Data Stack

Wearables and nearables are moving health data beyond the wrist into patches, rings, shoes, ingestibles, intimate devices, beds, rooms, and therapeutic systems. We mapped 130+ products to understand where body data is going next.

Editorial Picks

Mapping the Swiss Longevity Clinics

MoL Research21 May 2026

From Metrics to Better Living

Editorial06 May 2026

The Hardware of Longevity: Why We Are Ready for the Cellular Reset

Opinion30 Apr 2026

Who Buys Longevity?

MoL Research27 Apr 2026

A Global Rally for Life Extension

Editorial10 Apr 2026

Domestic Longevity Adoption in Switzerland and The “Sick Care” Problem

MoL Research30 Mar 2026

Nature - Biotechnology19 Jun 2026

Safety and efficacy analysis of in vivo lentiviral gene therapy in pre-clinical ARC syndrome models

Assessment of a liver-targeted integrating vector restoring cellular architecture and evaluating safety in preclinical models of infantile liver disease.

Key takeaways

Although causality remains unproven and no additional neoplasms have been reported 6.
They have also showed favourable safety profiles in early-phase in vivo clinical trials.
Our group has shown liver phenotype rescue using adeno-associated vector (AAV).

Frontiers - Health19 Jun 2026

The Immune System as a Regulator of Normal Physiology

Examine evolving models that reframe the immune system as a regulator of tolerance, tissue repair, metabolic balance, and homeostasis.

Key takeaways

Lions Eye Institute, University of Aberdeen, Aberdeen, United Kingdom, WA, 6014 2.
Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom, WA, 6014 3.
You have multiple emails registered with Frontiers: You don't have a Frontiers account ?

Nature - Biotechnology19 Jun 2026

A combinatorial therapeutic platform based on graphene–collagen cryogel and apoptotic vesicles for modulating hypertrophic scars

A combinatorial biomaterial and vesicle therapy is evaluated for modulating fibroblast-driven hypertrophic scarring and local delivery.

Key takeaways

Graphene–collagen cryogel reduced COL1A1, α-SMA, and Vimentin expression in HS fibroblasts.
Combined cryogel plus vesicle treatment lowered scar elevation index and increased M2 macrophages.
Adipose stem cell apoptotic vesicles decreased collagen and α-SMA expression in vitro.

Single-Point Insulin Sensitivity Estimator and Left Main and/or Three-Vessel Disease in Patients Aged 45 Years or Older with Acute Coronary Syndrome: Findings from the CCC-ACS Project

Assess the link between an easily measured insulin sensitivity marker and severe coronary artery patterns in older acute coronary syndrome patients.

Key takeaways

This study examined the association of the single-point insulin sensitivity estimator (SPISE).
You have multiple emails registered with Frontiers: You don't have a Frontiers account ?
Methods: This cross-sectional analysis was based on data from the CCC-ACS project.

Masters of Longevity - The Pulse

Wearables, Nearables, And The New Body-Data Stack

Mapping the Swiss Longevity Clinics

From Metrics to Better Living

The Hardware of Longevity: Why We Are Ready for the Cellular Reset

Who Buys Longevity?

A Global Rally for Life Extension

Domestic Longevity Adoption in Switzerland and The “Sick Care” Problem

Safety and efficacy analysis of in vivo lentiviral gene therapy in pre-clinical ARC syndrome models

The Immune System as a Regulator of Normal Physiology

A combinatorial therapeutic platform based on graphene–collagen cryogel and apoptotic vesicles for modulating hypertrophic scars

Single-Point Insulin Sensitivity Estimator and Left Main and/or Three-Vessel Disease in Patients Aged 45 Years or Older with Acute Coronary Syndrome: Findings from the CCC-ACS Project